Junshi Biosciences Receives NMPA Approval for JS212 in Advanced Solid Tumors
CompanyDrug

Junshi Biosciences Receives NMPA Approval for JS212 in Advanced Solid Tumors

Hengrui's Trastuzumab Rezetecan Nears 8th Breakthrough Therapy Designation
CompanyDrug

Hengrui’s Trastuzumab Rezetecan Nears 8th Breakthrough Therapy Designation

Fosun's Henlius Receives FDA Orphan Drug Designation for HER2-Targeting HLX22
CompanyDrug

Fosun’s Henlius Receives FDA Orphan Drug Designation for HER2-Targeting HLX22

Paratek Pharmaceuticals to Acquire Optinose for $330 Million
CompanyDeals

Paratek Pharmaceuticals to Acquire Optinose for $330 Million

Boji Medicine's Huasheng Transfers Glucosamine Sulfate Capsules Technology to Panlong
CompanyDeals

Boji Medical’s Huasheng Transfers Glucosamine Sulfate Capsules Technology to Panlong

Oxford BioTherapeutics Partners with Roche on Cancer Therapeutics Discovery
CompanyDeals

Oxford BioTherapeutics Partners with Roche on Cancer Therapeutics Discovery

Joyo Pharma's JYP0035 Receives Clinical Trial Approval for Breast Cancer Treatment
CompanyDrug

Joyo Pharma’s JYP0035 Receives Clinical Trial Approval for Breast Cancer Treatment

CDE Announces 92nd Batch of Reference Preparations for Generic Drug Evaluation
Policy / Regulatory

CDE Announces 92nd Batch of Reference Preparations for Generic Drug Evaluation

HutchMed's 2024 Financial Report Shows Dip in Revenue Amid Oncology Product Growth
Company

HutchMed’s 2024 Financial Report Shows Dip in Revenue Amid Oncology Product Growth

Servier and Black Diamond Therapeutics Ink Global Deal for BDTX-4933
CompanyDeals

Servier and Black Diamond Therapeutics Ink Global Deal for BDTX-4933

NMPA Seeks Public Input on Drug Trial Data Protection Measures
Policy / Regulatory

NMPA Seeks Public Input on Drug Trial Data Protection Measures

Telix Pharmaceuticals Gains Brazilian Approval for Prostate Cancer Diagnostic Agent TLX591-CDx
CompanyMedical Device

Telix Pharmaceuticals Gains Brazilian Approval for Prostate Cancer Diagnostic Agent TLX591-CDx